Health care lobbying in the United States

American Journal of Medicine

Volumn 116, Issue 7, 2004, Pages 474-477

  Landers, Steven H ^a   Sehgal, Ashwini R ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG INDUSTRY; HEALTH CARE DISTRIBUTION; HEALTH CARE FINANCING; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; INFORMATION RETRIEVAL; LAW; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; MEDICAL RECORD; PHYSICIAN; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; SOCIAL INSURANCE;

EID: 1642294791     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2003.10.037     Document Type: Article

References (14)

1. Igleheart J.K. Medicare's declining payments to physicians. N Engl J Med. 346:2002;1924-1930.
2. Gross C.P., Anderson G.F., Powe N.R. The relationship between funding by the National Institutes of Health and the burden of disease. N Engl J Med. 340:1999;1881-1887.
3. Kulynych J., Korn D. The new federal medical-privacy rule. N Engl J Med. 347:2002;1133-1134.
4. Landers S.H., Sehgal A.R. How do physicians lobby their members of Congress? Arch Intern Med. 160:2000;3248-3251.
5. United States Congress. Lobbying Disclosure Act of 1995. Public Law Number 104-65
6. Baumgartner F.R., Leech B.L. Interest niches and policy bandwagons patterns of interest group involvement in national politics. J Politics. 63:2001;1191-1213.
7. Center for Responsive Politics. Available at: http://www.opensecrets.org. Accessed January 3, 2002
8. Brody H. A matter of influence changing times call for changing policies on the presence of drug company reps in residency programs. Health Affairs. 21:2002;232-234.
9. Iglehart J.K. Medicare and prescription drugs. N Engl J Med. 344:2001;1010-1015.
10. Chren M.M., Landefeld C.S. Physicians' behavior and their interaction with drug companies. J Am Med Assoc. 271:1994;684-689.
11. Wazana A. Physicians and the pharmaceutical industry is a gift ever just a gift? J Am Med Assoc. 283:2000;373-380.
12. Moore S., Wolfe S.M., Lindes D., Douglas C.E. Epidemiology of failed tobacco control legislation. J Am Med Assoc. 272:1994;1171-1175.
13. Sharfstein J.M., Sharfstein S.S. Campaign contributions from the American Medical Political Action Committee to members of Congress. For or against the public health? N Engl J Med. 330:1994;32-37.
14. Bindman A.B., Grumbach K., Bernheim S., et al. Medicaid managed care's impact on safety-net clinics in California. Health Aff. 19:2000;194-202.